Amgen Loses CFO, Delays Earnings

Thousand Oaks-based Amgen lost its CFO Wednesday, and said that it is delaying its earnings to include results of a clinical trial. Amgen CFO Richard Nanula is leaving the company, and will be replaced by Robert Bradway, who was most recently Vice President, Operations Strategy. Bradway has also served at Morgan Stanley as an investment banker.